In CRC, it has been shown that the number of CD8+ cytotoxic TIL in PolE-mutated CRC significantly exceeds that of MMR proficient tumors but is not different from that of MMR deficient tumors. The gene discussed is MRC1; the disease is colorectal carcinoma.